A 32-year-old man presents with a 3-day history of pain, photophobia, and blurred vision in the right eye. On examination, the anterior chamber shows 2+ cells and flare with fibrin, and a posterior synechiae is noted. Intraocular pressure is 18 mmHg. Fundus examination is normal. There is no systemic history of concern. What is the most appropriate immediate next step in management?

Explanation

## Clinical Presentation Analysis This patient presents with acute anterior uveitis (AAU) characterized by: - Acute onset (3 days) pain, photophobia, and blurred vision - Anterior chamber inflammation (2+ cells and flare with fibrin) - Posterior synechiae formation - Normal IOP (18 mmHg) - Clear fundus ## Management Strategy for Acute Anterior Uveitis **Key Point:** Acute anterior uveitis is primarily managed with topical anti-inflammatory therapy and cycloplegia in the acute phase, regardless of etiology. ### Rationale for Topical Therapy First 1. **Immediate anti-inflammatory control**: Topical corticosteroids (prednisolone acetate 1%) penetrate the anterior segment effectively and reduce inflammation rapidly. 2. **Prevention of complications**: Frequent cycloplegic agents (homatropine 5%) prevent posterior synechiae formation and reduce pain by paralyzing the ciliary muscle. 3. **High local concentration**: Topical agents achieve therapeutic levels in the anterior chamber without systemic side effects. 4. **Standard of care**: Topical therapy is the first-line approach for uncomplicated AAU [cite:Kanski's Clinical Ophthalmology 9e Ch 6]. ### Dosing Schedule **High-Yield:** In acute AAU with significant inflammation (2+ cells), frequent topical corticosteroids (every 1–2 hours while awake) and cycloplegics (every 4–6 hours) are standard. ## When to Escalate | Scenario | Action | |----------|--------| | Mild AAU (trace–1+ cells) | Topical corticosteroids 4–6× daily + cycloplegic | | Moderate–severe AAU (2–3+ cells) | Topical corticosteroids every 1–2 hours + cycloplegic every 4–6 hours | | Hypopyon or severe fibrin | Add systemic corticosteroids | | Posterior uveitis or pan-uveitis | Systemic corticosteroids ± immunosuppressants | | Elevated IOP on topical steroids | Add IOP-lowering agents; consider steroid-sparing therapy | **Clinical Pearl:** Posterior synechiae in this case indicates moderate inflammation, but the normal IOP and clear fundus suggest isolated anterior involvement—topical therapy is sufficient as the first step. ## Systemic Workup Timing **Key Point:** Systemic investigation (HLA-B27, ANA, chest X-ray, ACE level) is performed *after* acute inflammation is controlled, not before starting treatment. Treatment should not be delayed pending serological results in acute AAU. --- ## Why Topical Therapy Is Superior Here ```mermaid flowchart TD A[Acute Anterior Uveitis]:::outcome --> B{Severity?}:::decision B -->|Mild: trace-1+ cells| C[Topical corticosteroids 4-6x daily + cycloplegic]:::action B -->|Moderate-severe: 2-3+ cells| D[Topical corticosteroids every 1-2 hours + cycloplegic]:::action C --> E{Response in 1-2 weeks?}:::decision D --> E E -->|Good| F[Taper topical steroids gradually]:::action E -->|Poor or posterior involvement| G[Add systemic corticosteroids]:::action G --> H[Investigate systemic etiology]:::action ```